Care Planning for Prostate Cancer Patients on Active Surveillance

Abstract

Active surveillance (AS) is recommended for patients with low-risk prostate cancer to prevent overtreatment and maintain sexual and urinary functioning. However, approximately 90% of AS-eligible patients opt for curative treatment and 25-50% discontinue AS within 2-5years without clinical evidence of cancer progression. Research is necessary to examine barriers and facilitators of informed decision-making and adherence to AS. We have conducted focus groups and personal interviews with patients (N = 32 patients) and care providers (N = 3) to examine barriers and facilitators of AS decisions and adherence. Factors that influence patients decisions to opt for AS include trust in the physicians expertise, good intentions, and skills in detecting cancer progression in a timely manner, and avoidance of sexual and urinary deterioration associated with curative treatment. The partners approval of AS played a significant role in the decision to opt for AS. Patient-provider communication and worries about cancer progression are major determinant factors of patients AS decisions.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2017
Accession Number
AD1043511

Entities

People

  • Nihal Mohamed

Organizations

  • Icahn School of Medicine at Mount Sinai

Tags

DTIC Thesaurus Topics

  • Acceptability
  • Adhesion
  • Beta Testing
  • Data Analysis
  • Department Of Defense
  • Education
  • Medical Personnel
  • Navigators
  • Neoplasms
  • New York
  • Patient Education
  • Pilot Studies
  • Prostate
  • Prostate Cancer
  • Quality Of Life
  • Surveillance
  • Training

Fields of Study

  • Medicine
  • Psychology

Readers

  • Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.
  • Oncology
  • Team-Based Human-Centered Cognitive Task Decision Making and Information Performance.